Hideyuki Iwai

3.3k total citations · 2 hit papers
30 papers, 2.6k citations indexed

About

Hideyuki Iwai is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Hideyuki Iwai has authored 30 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Hideyuki Iwai's work include Immune Cell Function and Interaction (9 papers), Immunotherapy and Immune Responses (9 papers) and T-cell and B-cell Immunology (7 papers). Hideyuki Iwai is often cited by papers focused on Immune Cell Function and Interaction (9 papers), Immunotherapy and Immune Responses (9 papers) and T-cell and B-cell Immunology (7 papers). Hideyuki Iwai collaborates with scholars based in Japan, United States and Cuba. Hideyuki Iwai's co-authors include Miyuki Azuma, Hideo Yagita∥, Hisaya Akiba, Tomohide Yamazaki, Ko Okumura, Drew M. Pardoll, Mami Aoki, Hironori Matsuda, Haruo Tsuchiya and Tahiro Shin and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Biochemical and Biophysical Research Communications.

In The Last Decade

Hideyuki Iwai

28 papers receiving 2.6k citations

Hit Papers

Expression of Programmed Death 1 Ligands by Murine T Cell... 2002 2026 2010 2018 2002 2003 250 500 750

Peers

Hideyuki Iwai
Ping Yu United States
Vijay K. Vanguri United States
JH Falkenburg Netherlands
Yonglian Sun United States
Ping Yu United States
Hideyuki Iwai
Citations per year, relative to Hideyuki Iwai Hideyuki Iwai (= 1×) peers Ping Yu

Countries citing papers authored by Hideyuki Iwai

Since Specialization
Citations

This map shows the geographic impact of Hideyuki Iwai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyuki Iwai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyuki Iwai more than expected).

Fields of papers citing papers by Hideyuki Iwai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideyuki Iwai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyuki Iwai. The network helps show where Hideyuki Iwai may publish in the future.

Co-authorship network of co-authors of Hideyuki Iwai

This figure shows the co-authorship network connecting the top 25 collaborators of Hideyuki Iwai. A scholar is included among the top collaborators of Hideyuki Iwai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyuki Iwai. Hideyuki Iwai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hosoya, Tadashi, Hideyuki Iwai, Ryuji Koike, et al.. (2025). Iguratimod, a promising therapeutic agent for COVID-19 that attenuates excessive inflammation in mouse models. European Journal of Pharmacology. 996. 177537–177537.
3.
Kamiya, Mari, Hideyuki Iwai, Yoshio Suzuki, et al.. (2024). Necroptosis in alveolar epithelial cells drives lung inflammation and injury caused by SARS-CoV-2 infection. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(8). 167472–167472. 4 indexed citations
4.
Tagawa, Yasuhiro, Tetsuya Saito, Hideyuki Iwai, et al.. (2024). ARID5B is a negative modulator of IL-6 production in rheumatoid arthritis synovial fibroblasts. Immunological Medicine. 47(3). 176–185. 1 indexed citations
5.
Sasaki, Hirokazu, et al.. (2023). Pathogenicity of functionally activated PD-1+CD8+ cells and counterattacks by muscular PD-L1 through IFNγ in myositis. Journal of Autoimmunity. 142. 103131–103131. 5 indexed citations
6.
Hosoya, Tadashi, Hideyuki Iwai, Yu Yamaguchi, et al.. (2014). Cell cycle regulation therapy combined with cytokine blockade enhances antiarthritic effects without increasing immune suppression. Annals of the Rheumatic Diseases. 75(1). 253–259. 35 indexed citations
7.
Su, Leon, Hideyuki Iwai, Jack T. Lin, & C. Garrison Fathman. (2009). The Transmembrane E3 Ligase GRAIL Ubiquitinates and Degrades CD83 on CD4 T Cells. The Journal of Immunology. 183(1). 438–444. 37 indexed citations
8.
Kodama, Keiichi, Atul J. Butte, Rémi J. Creusot, et al.. (2008). Tissue- and age-specific changes in gene expression during disease induction and progression in NOD mice. Clinical Immunology. 129(2). 195–201. 45 indexed citations
9.
Mizoguchi, Fumitaka, et al.. (2008). Varicella–zoster virus hepatitis in polymyositis. Modern Rheumatology. 18(3). 301–305. 4 indexed citations
11.
Ochi, Sae, Masayoshi Harigai, Fumitaka Mizoguchi, et al.. (2006). Leflunomide-related acute interstitial pneumonia in two patients with rheumatoid arthritis: autopsy findings with a mosaic pattern of acute and organizing diffuse alveolar damage. Modern Rheumatology. 16(5). 316–320. 21 indexed citations
12.
Tsushima, Fumihiko, Noriko Otsuki, Pornpan Youngnak, et al.. (2005). Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma. Oral Oncology. 42(3). 268–274. 86 indexed citations
13.
Tsushima, Fumihiko, Noriko Otsuki, Utako Machida, et al.. (2004). The expression of B7-H1 on keratinocytes in chronic inflammatory mucocutaneous disease and its regulatory role. Immunology Letters. 94(3). 215–222. 60 indexed citations
14.
Kanai∥, Takanori, Teruji Totsuka, Koji Uraushihara, et al.. (2003). Blockade of B7-H1 Suppresses the Development of Chronic Intestinal Inflammation. The Journal of Immunology. 171(8). 4156–4163. 148 indexed citations
15.
Iwai, Hideyuki, Masaaki Abe, Sachiko Hirose, et al.. (2003). Involvement of Inducible Costimulator-B7 Homologous Protein Costimulatory Pathway in Murine Lupus Nephritis. The Journal of Immunology. 171(6). 2848–2854. 102 indexed citations
16.
Youngnak, Pornpan, Yuko Kozono, Haruo Kozono, et al.. (2003). Differential binding properties of B7-H1 and B7-DC to programmed death-1. Biochemical and Biophysical Research Communications. 307(3). 672–677. 180 indexed citations
17.
Ansari, Mohammed Javeed, Alan D. Salama, Tanuja Chitnis, et al.. (2003). The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice. The Journal of Experimental Medicine. 198(1). 63–69. 654 indexed citations breakdown →
18.
Tsushima, Fumihiko, Hideyuki Iwai, Noriko Otsuki, et al.. (2003). Preferential contribution of B7‐H1 to programmed death‐1‐mediated regulation of hapten‐specific allergic inflammatory responses. European Journal of Immunology. 33(10). 2773–2782. 106 indexed citations
19.
Yamazaki, Tomohide, Hisaya Akiba, Hideyuki Iwai, et al.. (2002). Expression of Programmed Death 1 Ligands by Murine T Cells and APC. The Journal of Immunology. 169(10). 5538–5545. 798 indexed citations breakdown →
20.
Iwai, Hideyuki, Yuko Kozono, Sachiko Hirose, et al.. (2002). Amelioration of Collagen-Induced Arthritis by Blockade of Inducible Costimulator-B7 Homologous Protein Costimulation. The Journal of Immunology. 169(8). 4332–4339. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026